首页> 外文期刊>Biochemistry >Characterization of hK4 (Prostase), a Prostate-Specific Serine Protease: Activation of the Precursor of Prostate Specific Antigen (pro-PSA) and Single-Chain Urokinase-Type Plasminogen Activator and Degradation of Prostatic Acid Phosphatase
【24h】

Characterization of hK4 (Prostase), a Prostate-Specific Serine Protease: Activation of the Precursor of Prostate Specific Antigen (pro-PSA) and Single-Chain Urokinase-Type Plasminogen Activator and Degradation of Prostatic Acid Phosphatase

机译:hK4(蛋白酶),一种前列腺特异性丝氨酸蛋白酶的表征:前列腺特异性抗原(pro-PSA)和单链尿激酶型纤溶酶原激活物的激活以及前列腺酸性磷酸酶的降解

获取原文
获取原文并翻译 | 示例
           

摘要

hK4 (prostase, KLK4), a recently cloned prostate-specific serine protease and a member of the tissue kallikrein family, is a zymogen composed of 228 amino acid residues including an aminoterminal propiece, Ser-Cys-Ser-Gln-. A chimeric form of hK4 (ch-hK4) was constructed in which the propiece of hK4 was replaced by that of prostate-specific antigen (PSA) to create an activation site susceptible to trypsin-type proteases. ch-hK4 was expressed in Escherichia coli, isolated from inclusion bodies, refold4ed, and purified with an overall yield of 25%. The zymogen was readily self-activated during the refolding process to generate a active form (21 kDa) of hK4 (rhK4). rhK4 cleaved the chromogenic substrates Val-Leu-Arg-pNA (S-2266), Pro-Phe-Arg-pNA (S-2302), Ile-Glu-Gly-Arg-pNA (S-2222), and Val-Leu-Lys-pNA (S-2251), indicating that rhK4 has a trypsin-type substrate specificity. The rhK4 was inhibited by aprotinin (6 kDa), forming an equimolar 27 kDa complex. rhK4 readily activated both the precursor of PSA (pro-PSA) and single chain urokinase-type plasminogen activator (scuPA, pro-uPA). rhK4 also completely degraded prostatic acid phosphatase but failed to cleave serum albumin, another protein purified from human seminal plasma. These results indicate that hK4 may have a role in the physiologic processing of seminal plasma proteins such as pro-PSA, as well as in the pathogenesis of prostate cancer through its activation of pro-uPA.
机译:hK4(蛋白酶,KLK4)是一种最近克隆的前列腺特异性丝氨酸蛋白酶,是激肽释放酶家族组织的成员,是由228个氨基酸残基组成的酶原,包括一个氨基末端探针,Ser-Cys-Ser-Gln-。构建了hK4(ch-hK4)的嵌合形式,其中hK4的前体被前列腺特异性抗原(PSA)的前体所取代,从而形成了对胰蛋白酶型蛋白酶敏感的激活位点。 ch-hK4在大肠杆菌中表达,从包涵体分离,重折叠并纯化,总收率为25%。在重新折叠过程中,酶原很容易自我激活,从而生成hK4(rhK4)的活性形式(21 kDa)。 rhK4裂解了发色底物Val-Leu-Arg-pNA(S-2266),Pro-Phe-Arg-pNA(S-2302),Ile-Glu-Gly-Arg-pNA(S-2222)和Val-Leu -Lys-pNA(S-2251),表明rhK4具有胰蛋白酶型底物特异性。 rhK4被抑肽酶(6 kDa)抑制,形成等摩尔的27 kDa复合物。 rhK4可以轻松激活PSA的前体(pro-PSA)和单链尿激酶型纤溶酶原激活剂(scuPA,pro-uPA)。 rhK4还可以完全降解前列腺酸磷酸酶,但不能裂解血清白蛋白,后者是从人精浆中纯化得到的另一种蛋白。这些结果表明,hK4可能在诸如pro-PSA之类的精浆蛋白的生理处理中,以及通过其对uPA的活化而在前列腺癌的发病中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号